Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol pMDI vs DPI in COPD
NCT00742248Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2004; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00742248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742248.